Prosecution Insights
Last updated: November 04, 2026
Application No. 18/155,441

METHOD OF MAKING MONOACYLGLYCERIDE OILS AND FOOD PRODUCTS CONTAINING MONOACYLGLYCERIDE OILS

Non-Final OA §112
Filed
Jan 17, 2023
Priority
Oct 13, 2017 — provisional 62/571,910 +5 more
Examiner
O'HERN, BRENT T
Art Unit
1793
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Glycosbio Inc.
OA Round
7 (Non-Final)
79%
Grant Probability
Favorable
7-8
OA Rounds
0m
Est. Remaining
98%
With Interview

Examiner Intelligence

Grants 79% — above average
79%
Career Allowance Rate
1125 granted / 1430 resolved
+13.7% vs TC avg
Strong +19% interview lift
Without
With
+19.3%
Interview Lift
resolved cases with interview
Typical timeline
2y 8m
Avg Prosecution
62 currently pending
Career history
1467
Total Applications
across all art units

Statute-Specific Performance

§101
0.4%
-39.6% vs TC avg
§103
43.4%
+3.4% vs TC avg
§102
13.0%
-27.0% vs TC avg
§112
37.4%
-2.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1430 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 9/15/2026 has been entered. Claims Claims 1, 6, 31, 34, 36, 38, 49-56 are pending with claims 49-56 new. Examiner’s Note When making amendments to the claims Applicant is advised to be careful and not add new matter. Applicant is advised to precisely point out where in the disclosure as filed, not the PGPUB, support is present for any amendments. WITHDRAWN OBJECTIONS All objections of record in the Office Action mailed 7/15/2026 have been withdrawn due to Applicant’s amendments in the Paper filed 9/15/2026. WITHDRAWN REJECTIONS All rejections of record in the Office Action mailed 7/15/2026 have been withdrawn due to Applicant’s amendments in the Paper filed 9/15/2026. NEW OBJECTIONS Specification The specification is objected to as failing to provide proper antecedent basis for the claimed subject matter. See 37 CFR 1.75(d)(1) and MPEP § 608.01(o). Correction of the following is required: The phrases “tocopherols derived from and naturally present in an oil source of the processed oil” in claim 1, line 14 and “tocopherols derived from and naturally present in an oil source of the processed oil” in claim 34, line 12 are not described in the text of the Specification. Applicant is advised to consider amending the text of the Specification to incorporate this language while being careful not to add new matter. Paragraph [0015] refers to “present in the oil source” and not “present in an oil source of the processed oil”. The claims do not state the tocopherols are 1% or some other % by weight of the processed oil like the ingredients set forth earlier in the claims. PNG media_image1.png 250 650 media_image1.png Greyscale NEW REJECTIONS The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Official Correspondence. Claim Rejections - 35 USC § 112 Claims 51-54 are rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. The phrase “wherein the amount of each of oleic acid, linoleic acid, and linolenic acid, in free fatty acid or glyceride form, is within about 10% of the corresponding amount of oleic acid, linoleic acid, and linolenic acid, respectively, in the oil source” in claim 51, lines 1-4 is new matter. The Specification at paragraphs 56 and 57 do not make this comparison but rather compare to “pre-processed oil”. The “oil source” language in the claims is different than “pre-processed oil” in paragraphs 56, 57 of the Specification. PNG media_image2.png 68 630 media_image2.png Greyscale PNG media_image3.png 114 636 media_image3.png Greyscale The phrase “wherein the amount of each of oleic acid, linoleic acid, and linolenic acid, in free fatty acid or glyceride form, is within about 1% of the corresponding amount of oleic acid, linoleic acid, and linolenic acid, respectively, in the oil source” in claim 52, lines 1-4 is new matter. The Specification at paragraphs 56 and 58 do not make this comparison but rather compares to “pre-processed oil”. The “oil source” language in the claim is different than “pre-processed oil” in paragraphs 56 and 58 of the Specification. PNG media_image2.png 68 630 media_image2.png Greyscale PNG media_image4.png 115 632 media_image4.png Greyscale The phrase “wherein the amount of each of oleic acid, linoleic acid, and linolenic acid, in free fatty acid or glyceride form, is within about 10% of the corresponding amount of oleic acid, linoleic acid, and linolenic acid, respectively, in the oil source” in claim 53, lines 1-4 is new matter. The Specification at paragraphs 56 and 57 do not make this comparison but rather compares to “pre-processed oil”. The “oil source” language in the claims is different than “pre-processed oil” in paragraphs 56 and 57 of the Specification. PNG media_image2.png 68 630 media_image2.png Greyscale PNG media_image3.png 114 636 media_image3.png Greyscale The phrase “wherein the amount of each of oleic acid, linoleic acid, and linolenic acid, in free fatty acid or glyceride form, is within about 1% of the corresponding amount of oleic acid, linoleic acid, and linolenic acid, respectively, in the oil source” in claim 54, lines 1-4 is new matter. The Specification at paragraphs 56 and 58 do not make this comparison but rather compares to “pre-processed oil”. The “oil source” language in the claim is different than “pre-processed oil” in paragraphs 56, 58 of the Specification. PNG media_image2.png 68 630 media_image2.png Greyscale PNG media_image4.png 115 632 media_image4.png Greyscale The Specification at paragraphs 56 and 57 do not make this comparison but rather compares to “pre-processed oil”. The “oil source” language in the claim is different than “pre-processed oil” in paragraphs 56, 57 of the Specification. Claims 1, 6, 31, 34, 36, 38, 49-56 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. The phrase “tocopherols derived from and naturally present in an oil source of the processed oil” in claim 1, line 14 is vague and indefinite as it unclear whether anything other than “tocopherols” are present in the “processed oil” per this language as the claims are directed to a product and not a process of making, thus, it is unclear whether this language is superfluous or something else. The phrase “tocopherols derived from and naturally present in an oil source of the processed oil” in claim 1, line 14 is vague and indefinite as it unclear whether this language is inferring only the presence of tocopherols and no oil at all as this language appears to infer tocopherols have been removed from an oil source. The phrase “tocopherols derived from and naturally present in an oil source of the processed oil” in claim 1, line 14 is vague and indefinite as it unclear what is the difference between tocopherols that are “naturally present” and tocopherols that are both “derived from” and “naturally present” as there does not appear to be a distinction. The phrase “tocopherols derived from and naturally present in an oil source of the processed oil” in claim 1, line 14 is vague and indefinite as it unclear whether both “tocopherols” and an “oil source” are present in the processed oil or just tocopherols as the “of the processed oil” language appears to infer both are present, however, the “processed oil” appears to infer there is not an “oil source” as any “source” has been transformed into processed oil. The phrase “tocopherols derived from and naturally present in an oil source of the processed oil” in claim 1, line 14 is vague and indefinite as it unclear what is the difference between tocopherols that are naturally present and tocopherols that are not naturally present as there does not appear to be any difference between identical molecules. The phrase “tocopherols derived from and naturally present in an oil source of the processed oil” in claim 1, line 14 is vague and indefinite as it unclear what is the difference between tocopherols that are “derived from” and tocopherols that are “not derived from” as there does not appear to be any difference between identical molecules. The phrase “tocopherols … oil source of the processed oil” in claim 1, line 14 is vague and indefinite as it unclear what limitations can be gleamed from the “oil source” language as “oil source” is not present in the processed oil. The phrase “tocopherols derived from and naturally present in an oil source of the processed oil” in claim 34, line 12 is vague and indefinite as it unclear whether anything other than “tocopherols” are present in the “processed oil” per this language as the claims are directed to a product and not a process of making, thus, it is unclear whether this language is superfluous or something else. The phrase “tocopherols derived from and naturally present in an oil source of the processed oil” in claim 34, line 12 is vague and indefinite as it unclear whether this language is inferring only the presence of tocopherols and no oil at all as this language appears to infer tocopherols have been removed from an oil source. The phrase “tocopherols derived from and naturally present in an oil source of the processed oil” in claim 34, line 12 is vague and indefinite as it unclear what is the difference between tocopherols that are “naturally present” and tocopherols that are both “derived from” and “naturally present” as there does not appear to be a distinction. The phrase “tocopherols derived from and naturally present in an oil source of the processed oil” in claim 34, line 12 is vague and indefinite as it unclear whether both “tocopherols” and an “oil source” are present in the processed oil or just tocopherols as the “of the processed oil” language appears to infer both are present, however, the “processed oil” appears to infer there is not an “oil source” as any “source” has been transformed into processed oil. The phrase “tocopherols derived from and naturally present in an oil source of the processed oil” in claim 34, line 12 is vague and indefinite as it unclear what is the difference between tocopherols that are naturally present and tocopherols that are not naturally present as there does not appear to be any difference between identical molecules. The phrase “tocopherols derived from and naturally present in an oil source of the processed oil” in claim 34, line 12 is vague and indefinite as it unclear what is the difference between tocopherols that are “derived from” and tocopherols that are “not derived from” as there does not appear to be any difference between identical molecules. The phrase “wherein the amount of each of oleic acid, linoleic acid, and linolenic acid, in free fatty acid or glyceride form, is within about 10% of the corresponding amount of oleic acid, linoleic acid, and linolenic acid, respectively, in the oil source” in claim 51, lines 1-4 is vague and indefinite as it is unclear what the fatty acid content is as the “oil source” is not defined. Furthermore, these claims are not process claims, thus, the specific characteristics of a source oil are irrelevant as patentability is based on the composition of the “processed oil” and not the composition of a “source oil”. The phrase “10%” in claim 51, line 2 is vague and indefinite as it is unclear whether the % is “% weight” or “% mole” or something else. The phrase “wherein the amount of each of oleic acid, linoleic acid, and linolenic acid, in free fatty acid or glyceride form, is within about 1% of the corresponding amount of oleic acid, linoleic acid, and linolenic acid, respectively, in the oil source” in claim 52, lines 1-4 is vague and indefinite as it is unclear what the fatty acid content is as the “oil source” is not defined. Furthermore, these claims are not process claims, thus, the specific characteristics of a source oil are irrelevant as patentability is based on the composition of the “processed oil” and not the composition of a “source oil”. The phrase “1%” in claim 52, line 2 is vague and indefinite as it is unclear whether the % is “% weight” or “% mole” or something else. The phrase “wherein the amount of each of oleic acid, linoleic acid, and linolenic acid, in free fatty acid or glyceride form, is within about 10% of the corresponding amount of oleic acid, linoleic acid, and linolenic acid, respectively, in the oil source” in claim 53, lines 1-4 is vague and indefinite as it is unclear what the fatty acid content is as the “oil source” is not defined. Furthermore, these claims are not process claims, thus, the specific characteristics of a source oil are irrelevant as patentability is based on the composition of the “processed oil” and not the composition of a “source oil”. The phrase “10%” in claim 53, line 2 is vague and indefinite as it is unclear whether the % is “% weight” or “% mole” or something else. The phrase “wherein the amount of each of oleic acid, linoleic acid, and linolenic acid, in free fatty acid or glyceride form, is within about 1% of the corresponding amount of oleic acid, linoleic acid, and linolenic acid, respectively, in the oil source” in claim 54, lines 1-4 is vague and indefinite as it is unclear what the fatty acid content is as the “oil source” is not defined. Furthermore, these claims are not process claims, thus, the specific characteristics of a source oil are irrelevant as patentability is based on the composition of the “processed oil” and not the composition of a “source oil”. The phrase “1%” in claim 54, line 2 is vague and indefinite as it is unclear whether the % is “% weight” or “% mole” or something else. The phrase “oil source is olive oil” in claim 55, line 1 is vague and indefinite as it is unclear what limitations can be gleamed from the “olive oil” language as olive oil is not present in the processed oil and the claims are not process claims. The phrase “oil source is sunflower oil” in claim 56, line 1 is vague and indefinite as it is unclear what limitations can be gleamed from the “sunflower oil” language as sunflower oil is not present in the processed oil and the claims are not process claims. Clarification and/or correction required. ANSWERS TO APPLICANT’S ARGUMENTS The limitations of the amended/new claims are discussed above. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to BRENT T O'HERN whose telephone number is (571)272-6385. The examiner can normally be reached M-Th 5:00 am - 3:30 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Emily Le can be reached at 571-272-0903. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /BRENT T O'HERN/ Primary Examiner, Art Unit 1793 September 18, 2026
Read full office action

Prosecution Timeline

Show 16 earlier events
Nov 12, 2025
Response after Non-Final Action
Nov 18, 2025
Non-Final Rejection mailed — §112
May 13, 2026
Response after Non-Final Action
May 13, 2026
Response Filed
Jul 15, 2026
Final Rejection mailed — §112
Sep 15, 2026
Request for Continued Examination
Sep 16, 2026
Response after Non-Final Action
Sep 23, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12781183
LACTIC ACID BACTERIAL STRAINS WITH IMPROVED TEXTURIZING PROPERTIES
3y 3m to grant Granted Nov 03, 2026
Patent 12779025
METHODS AND COMPOSITIONS FOR ORALLY DOSING ANIMALS
2y 5m to grant Granted Nov 03, 2026
Patent 12774429
A PROCESS FOR MAKING A VEGETABLE FAT COMPOSITION WITH AN INCREASED AMOUNT OF SN2 POSITIONED PALMITIC ACID
3y 8m to grant Granted Oct 27, 2026
Patent 12765586
PROCESS FOR PRODUCTION OF CONCENTRATES OF CHELATED MINERALS WITH SOYBEAN AMINO ACIDS AND/OR SOYBEAN PROTEIN, AND RELATED PRODUCT
3y 9m to grant Granted Oct 20, 2026
Patent 12765568
METHOD FOR PRODUCING FROZEN PROCESSED COOKED RICE FOOD
3y 0m to grant Granted Oct 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

7-8
Expected OA Rounds
79%
Grant Probability
98%
With Interview (+19.3%)
2y 8m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 1430 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month